Axon Enterprise, Inc (NASDAQ:AXON) Receives Average Rating of "Moderate Buy" from Brokerages

Key Points

• Axon Enterprise, Inc. has received an average rating of "Moderate Buy" from analysts, with 13 out of 16 recommending a buy.
• The average twelve-month target price for Axon stock among brokerages is $837.69, indicating potential upside for investors.
• In its latest quarterly earnings, Axon reported an EPS of $2.12, exceeding expectations and showcasing a 32.6% year-over-year revenue growth.

Shares of Axon Enterprise, Inc (NASDAQ:AXON - Get Free Report) have received an average rating of "Moderate Buy" from the sixteen analysts that are currently covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $837.6923.

A number of analysts recently commented on AXON shares. Wolfe Research started coverage on shares of Axon Enterprise in a research note on Monday, July 7th. They set an "outperform" rating on the stock. Raymond James Financial restated an "outperform" rating and set a $855.00 price target (up from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Bank of America upped their price target on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Zacks Research lowered shares of Axon Enterprise from a "strong-buy" rating to a "hold" rating in a report on Tuesday, September 2nd. Finally, JPMorgan Chase & Co. upped their target price on shares of Axon Enterprise from $730.00 to $850.00 and gave the stock an "overweight" rating in a report on Thursday, July 17th.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $728.41 on Friday. The stock has a market capitalization of $57.18 billion, a P/E ratio of 179.85, a PEG ratio of 26.73 and a beta of 1.40. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The firm's 50 day moving average is $765.93 and its 200 day moving average is $679.57. Axon Enterprise has a 12 month low of $346.71 and a 12 month high of $885.91.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating analysts' consensus estimates of $1.54 by $0.58. The company had revenue of $668.54 million for the quarter, compared to analysts' expectations of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. Axon Enterprise's revenue was up 32.6% compared to the same quarter last year. During the same period in the prior year, the company posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. On average, sell-side analysts anticipate that Axon Enterprise will post 5.8 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In related news, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $831.29, for a total transaction of $8,312,900.00. Following the sale, the chief executive officer owned 3,053,982 shares of the company's stock, valued at approximately $2,538,744,696.78. This represents a 0.33% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Jeffrey C. Kunins sold 7,891 shares of the company's stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the sale, the insider directly owned 144,538 shares in the company, valued at $108,417,953.80. This trade represents a 5.18% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 34,865 shares of company stock worth $26,926,433 in the last ninety days. Insiders own 4.40% of the company's stock.

Hedge Funds Weigh In On Axon Enterprise

A number of institutional investors have recently made changes to their positions in the stock. Q3 Asset Management bought a new position in shares of Axon Enterprise in the 2nd quarter worth $728,000. Total Investment Management Inc. bought a new position in shares of Axon Enterprise in the 2nd quarter worth $84,000. Orion Porfolio Solutions LLC increased its holdings in shares of Axon Enterprise by 23.3% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 4,544 shares of the biotechnology company's stock worth $3,762,000 after buying an additional 858 shares during the last quarter. Munro Partners bought a new position in shares of Axon Enterprise in the 2nd quarter worth $62,610,000. Finally, MASTERINVEST Kapitalanlage GmbH bought a new position in shares of Axon Enterprise in the 2nd quarter worth $394,000. Institutional investors own 79.08% of the company's stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.